Technology-话题@MedSci

#Technology#

57篇内容 | 1603人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1795626, encodeId=e6fb1e9562605, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Biotechnology：调控蛋白质稳态，司龙龙团队建立PROTAC减毒疫苗新策略, objectType=article, longId=731364, objectId=6c56e31364d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c56e31364d4, replyNumber=0, likeNumber=103, createdTime=2023-05-01, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c56e31364d4, moduleTitle=Nature Biotechnology：调控蛋白质稳态，司龙龙团队建立PROTAC减毒疫苗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c56e31364d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795623, encodeId=4f0b1e9562328, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=J Nanobiotechnology：多功能复合水凝胶作为内源性和外源性协同调节剂提高银屑病的疗效, objectType=article, longId=724095, objectId=76d0e24095b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76d0e24095b8, replyNumber=0, likeNumber=90, createdTime=2023-02-11, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76d0e24095b8, moduleTitle=J Nanobiotechnology：多功能复合水凝胶作为内源性和外源性协同调节剂提高银屑病的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76d0e24095b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795619, encodeId=bec41e9561938, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Biotechnology：发现治疗白血病的新型免疫疗法, objectType=article, longId=291799, objectId=443f291e99a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=443f291e99a1, replyNumber=0, likeNumber=67, createdTime=2022-06-23, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=443f291e99a1, moduleTitle=Nature Biotechnology：发现治疗白血病的新型免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=443f291e99a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795621, encodeId=ebeb1e95621e5, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Biotechnology：瞒天过海，给细菌穿上“隐身衣”，让它们绕过免疫系统去攻击癌细胞, objectType=article, longId=301267, objectId=f87030126e8b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f87030126e8b, replyNumber=0, likeNumber=83, createdTime=2022-05-16, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f87030126e8b, moduleTitle=Nature Biotechnology：瞒天过海，给细菌穿上“隐身衣”，让它们绕过免疫系统去攻击癌细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f87030126e8b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795625, encodeId=bcc61e9562579, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Biotechnology：深度视觉蛋白质组学：对单个癌细胞空间表征，发现癌症治疗新靶点, objectType=article, longId=727872, objectId=2330e27872ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2330e27872ac, replyNumber=0, likeNumber=97, createdTime=2023-02-19, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2330e27872ac, moduleTitle=Nature Biotechnology：深度视觉蛋白质组学：对单个癌细胞空间表征，发现癌症治疗新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2330e27872ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795618, encodeId=1a6d1e9561880, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Nanotechnology：惊呆了，癌细胞学会了三十六计，釜底抽薪，偷走免疫细胞的线粒体，实现免疫逃逸, objectType=article, longId=221090, objectId=304122109079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=304122109079, replyNumber=0, likeNumber=78, createdTime=2022-01-29, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=304122109079, moduleTitle=Nature Nanotechnology：惊呆了，癌细胞学会了三十六计，釜底抽薪，偷走免疫细胞的线粒体，实现免疫逃逸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=304122109079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795624, encodeId=68481e9562471, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Nanotechnology：厦门大学刘刚团队开发新型纳米囊泡疫苗平台，可介导超强抗肿瘤免疫活性, objectType=article, longId=724588, objectId=b32fe2458803, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b32fe2458803, replyNumber=0, likeNumber=83, createdTime=2022-05-19, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b32fe2458803, moduleTitle=Nature Nanotechnology：厦门大学刘刚团队开发新型纳米囊泡疫苗平台，可介导超强抗肿瘤免疫活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b32fe2458803)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795617, encodeId=ed0c1e95617eb, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合, objectType=article, longId=217335, objectId=d79721e335a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d79721e335a4, replyNumber=0, likeNumber=88, createdTime=2022-07-26, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d79721e335a4, moduleTitle=J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d79721e335a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795622, encodeId=e9e91e95622d9, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Biotechnology：斯坦福/牛津纳米孔/谷歌/英伟达合作，开发超快速纳米孔测序，7小时发现致病基因突变, objectType=article, longId=301958, objectId=3051301958c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3051301958c7, replyNumber=0, likeNumber=77, createdTime=2022-08-11, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3051301958c7, moduleTitle=Nature Biotechnology：斯坦福/牛津纳米孔/谷歌/英伟达合作，开发超快速纳米孔测序，7小时发现致病基因突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3051301958c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795615, encodeId=3ece1e95615d2, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Nanotechnology：松弛素通过肝巨噬细胞外泌体缓解肝纤维化, objectType=article, longId=209881, objectId=f125209881cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f125209881cf, replyNumber=0, likeNumber=74, createdTime=2021-06-27, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f125209881cf, moduleTitle=Nature Nanotechnology：松弛素通过肝巨噬细胞外泌体缓解肝纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f125209881cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795620, encodeId=a52f1e956207e, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Accutar Biotechnology宣布FDA批准AC0176用于治疗前列腺癌的1期试验的IND申请, objectType=article, longId=293053, objectId=e61729305300, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e61729305300, replyNumber=0, likeNumber=83, createdTime=2022-09-14, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e61729305300, moduleTitle=Accutar Biotechnology宣布FDA批准AC0176用于治疗前列腺癌的1期试验的IND申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e61729305300)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795616, encodeId=28801e95616c6, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=腾盛博药、Vir Biotechnology和VBI Vaccines宣布启动BRII-835 (VIR-2218)联合BRII-179 (VBI-2601)治疗乙型肝炎的2期临床试验, objectType=article, longId=210372, objectId=3bb22103e2fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bb22103e2fc, replyNumber=0, likeNumber=92, createdTime=2021-11-27, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bb22103e2fc, moduleTitle=腾盛博药、Vir Biotechnology和VBI Vaccines宣布启动BRII-835 (VIR-2218)联合BRII-179 (VBI-2601)治疗乙型肝炎的2期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bb22103e2fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795613, encodeId=36a21e95613d5, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature：Vir Biotechnology的增强型单克隆抗体可诱导抗病毒感染的CD8+T细胞应答, objectType=article, longId=201934, objectId=9da620193435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da620193435, replyNumber=0, likeNumber=77, createdTime=2020-12-05, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da620193435, moduleTitle=Nature：Vir Biotechnology的增强型单克隆抗体可诱导抗病毒感染的CD8+T细胞应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da620193435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795612, encodeId=43a81e956126f, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=GSk/Vir Biotechnology中和抗体治疗早期COVID-19进入III期阶段, objectType=article, longId=201860, objectId=7aa320186063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aa320186063, replyNumber=0, likeNumber=76, createdTime=2021-02-14, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aa320186063, moduleTitle=GSk/Vir Biotechnology中和抗体治疗早期COVID-19进入III期阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aa320186063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795611, encodeId=8fc91e9561158, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=GSK和Vir Biotechnology将抗SARS-CoV-2单克隆抗体推荐到III期临床, objectType=article, longId=201817, objectId=ab3520181ee0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab3520181ee0, replyNumber=0, likeNumber=93, createdTime=2021-08-07, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab3520181ee0, moduleTitle=GSK和Vir Biotechnology将抗SARS-CoV-2单克隆抗体推荐到III期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab3520181ee0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795614, encodeId=a35e1e956147f, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Nature Biotechnology：高血压延迟病毒清除并加剧COVID-19患者的气道炎症, objectType=article, longId=205668, objectId=4f27205668e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f27205668e2, replyNumber=0, likeNumber=84, createdTime=2021-09-21, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f27205668e2, moduleTitle=Nature Biotechnology：高血压延迟病毒清除并加剧COVID-19患者的气道炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f27205668e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795608, encodeId=de3b1e9560821, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=J Nanobiotechnology：氧化铈纳米颗粒改善对乙酰氨基酚引起的肝损伤和部分肝切除术后肝脏的再生, objectType=article, longId=190337, objectId=dea019033ee5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dea019033ee5, replyNumber=0, likeNumber=69, createdTime=2020-07-22, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dea019033ee5, moduleTitle=J Nanobiotechnology：氧化铈纳米颗粒改善对乙酰氨基酚引起的肝损伤和部分肝切除术后肝脏的再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dea019033ee5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795607, encodeId=b15b1e9560711, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=RNAi治疗COVID-19：Alnylam与Vir Biotechnology联手开发, objectType=article, longId=189413, objectId=9aac1894137a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9aac1894137a, replyNumber=0, likeNumber=72, createdTime=2020-06-06, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9aac1894137a, moduleTitle=RNAi治疗COVID-19：Alnylam与Vir Biotechnology联手开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9aac1894137a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795610, encodeId=f18c1e956105b, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=GSK与Vir Biotechnology达成2.5亿美元交易，合作开发针对新型冠状病毒的化合物和抗体, objectType=article, longId=191695, objectId=5da71916955e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5da71916955e, replyNumber=0, likeNumber=107, createdTime=2020-06-27, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5da71916955e, moduleTitle=GSK与Vir Biotechnology达成2.5亿美元交易，合作开发针对新型冠状病毒的化合物和抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5da71916955e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795609, encodeId=10481e9560933, content=<a href='/topic/show?id=87881e249e8' target=_blank style='color:#2F92EE;'>#Technology#</a>, objectTitle=Environmental Science & Technology：纸质分析设备检测社区废水，为COVID-19提供预警, objectType=article, longId=191363, objectId=d30c19136387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d30c19136387, replyNumber=0, likeNumber=87, createdTime=2020-08-19, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d30c19136387, moduleTitle=Environmental Science & Technology：纸质分析设备检测社区废水，为COVID-19提供预警, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d30c19136387)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Technology

2020-05-29

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature Biotechnology：调控蛋白质稳态，司龙龙团队建立PROTAC减毒疫苗新策略

2023-05-01

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

J Nanobiotechnology：多功能复合水凝胶作为内源性和外源性协同调节剂提高银屑病的疗效

2023-02-11

docwu2019 (审核中...)

前往app查看评论内容

#Technology#

Nature Biotechnology：发现治疗白血病的新型免疫疗法

2022-06-23

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature Biotechnology：瞒天过海，给细菌穿上“隐身衣”，让它们绕过免疫系统去攻击癌细胞

2022-05-16

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature Biotechnology：深度视觉蛋白质组学：对单个癌细胞空间表征，发现癌症治疗新靶点

2023-02-19

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature Nanotechnology：惊呆了，癌细胞学会了三十六计，釜底抽薪，偷走免疫细胞的线粒体，实现免疫逃逸

2022-01-29

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature Nanotechnology：厦门大学刘刚团队开发新型纳米囊泡疫苗平台，可介导超强抗肿瘤免疫活性

2022-05-19

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

J Nanobiotechnology：上海长征医院杨立利课题组发现工程化的外泌体miR-181b通过调节巨噬细胞极化改善骨整合

2022-07-26

爆笑小医 (审核中...)

前往app查看评论内容

#Technology#

Nature Biotechnology：斯坦福/牛津纳米孔/谷歌/英伟达合作，开发超快速纳米孔测序，7小时发现致病基因突变

2022-08-11

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature Nanotechnology：松弛素通过肝巨噬细胞外泌体缓解肝纤维化

2021-06-27

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Accutar Biotechnology宣布FDA批准AC0176用于治疗前列腺癌的1期试验的IND申请

2022-09-14

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

腾盛博药、Vir Biotechnology和VBI Vaccines宣布启动BRII-835 (VIR-2218)联合BRII-179 (VBI-2601)治疗乙型肝炎的2期临床试验

2021-11-27

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature：Vir Biotechnology的增强型单克隆抗体可诱导抗病毒感染的CD8+T细胞应答

2020-12-05

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

GSk/Vir Biotechnology中和抗体治疗早期COVID-19进入III期阶段

2021-02-14

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

GSK和Vir Biotechnology将抗SARS-CoV-2单克隆抗体推荐到III期临床

2021-08-07

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Nature Biotechnology：高血压延迟病毒清除并加剧COVID-19患者的气道炎症

2021-09-21

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

J Nanobiotechnology：氧化铈纳米颗粒改善对乙酰氨基酚引起的肝损伤和部分肝切除术后肝脏的再生

2020-07-22

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

RNAi治疗COVID-19：Alnylam与Vir Biotechnology联手开发

2020-06-06

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

GSK与Vir Biotechnology达成2.5亿美元交易，合作开发针对新型冠状病毒的化合物和抗体

2020-06-27

fzwish20000 (审核中...)

前往app查看评论内容

#Technology#

Environmental Science & Technology：纸质分析设备检测社区废水，为COVID-19提供预警

2020-08-19

科室
- - 订阅+
  - 更多科室
工具
服务